Item Type | Name |
Concept
|
Cerebral Hemorrhage
|
Concept
|
Intracranial Hemorrhages
|
Concept
|
Hemorrhage
|
Academic Article
|
Hemorrhage and resuscitation alter the expression of ICAM-1 and P-selectin in mice.
|
Academic Article
|
Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo.
|
Academic Article
|
Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells.
|
Academic Article
|
Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart.
|
Academic Article
|
Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression.
|
Academic Article
|
Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein.
|
Academic Article
|
Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia.
|
Academic Article
|
Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta.
|
Academic Article
|
Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5'-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia.
|
Academic Article
|
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion.
|
Academic Article
|
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
|
Academic Article
|
Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice.
|
Academic Article
|
Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury.
|
Academic Article
|
Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice.
|
Academic Article
|
Effects of treatment with the 21-aminosteroid, U7438F, on pulmonary cytokine expression following hemorrhage and resuscitation.
|
Academic Article
|
Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs.
|
Academic Article
|
Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury.
|
Academic Article
|
Cytokine expression in Peyer's patches following hemorrhage and resuscitation.
|
Academic Article
|
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
|
Academic Article
|
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
|
Academic Article
|
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
|
Academic Article
|
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
|
Academic Article
|
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
|
Academic Article
|
Biomarkers of cavernous angioma with symptomatic hemorrhage.
|
Academic Article
|
Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
|
Academic Article
|
Novel Murine Models of Cerebral Cavernous Malformations.
|
Academic Article
|
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
|
Academic Article
|
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation.
|
Academic Article
|
Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth.
|
Academic Article
|
Impact of socioeconomics and race on clinical follow-up and trial enrollment and adherence in cerebral cavernous malformation.
|
Academic Article
|
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
|